- Expanding manufacturing capabilities, including new sites and innovative technologies, to support an exciting pipeline of products, especially in cancer vaccines
- How nurturing bold and curious talent fosters a mindset where taking risks is encouraged and failure is seen as a learning opportunity
- The integration of human capital, business processes, and emerging technologies to enhance operational efficiency
- Exploring how to work more effectively with regulatory bodies to ensure innovation isn’t stifled, while also holding them accountable
- The role of robotics and manufacturing advancements in Europe and how these innovations shape Moderna’s global strategy
Jerh Collins
Chief Technical Operations & Quality Officer
Moderna
As Chief Technical Operations and Quality Officer, Dr. Collins is responsible for the technical development, quality, and supply of preclinical, clinical and commercial programs within Moderna’s portfolio.
Dr. Collins joined Moderna from Novartis, where he held roles of increasing responsibility over the last nearly 30 years, focused on pharmaceutical production and manufacturing, including roles serving as Head of Global Chemical Operations and Anti-Infectives and as Head of Global Chemical Operations.
Dr. Collins received his Bachelor of Science in Chemistry and his Ph.D. in Organic Chemistry from University College Cork, Ireland. He also conducted post-doctoral cancer research at Arizona State University.
